Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS – Sarepta Therapeutics

Business News

  1. Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS  Sarepta Therapeutics
  2. FDA probes death of patient on Sarepta’s Elevidys, partner Roche says death unrelated to therapy  Reuters
  3. For many Duchenne families, halt to gene therapy is heartbreak upon heartbreak  statnews.com
  4. ‘We will crack gene therapy’: Elevidys fallout doesn’t dent Roche’s hopes for modality  Fierce Biotech
  5. FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report  Fierce Pharma

Source: Business News

/by